Search results
Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to...
Simply Wall St. via Yahoo Finance UK· 4 days agoKey Insights Significantly high institutional ownership implies Amgen's stock price is sensitive to...
This Deeply Discounted CEF Mini-Portfolio Yields 9.2%
Forbes· 4 days agoUnlike a lot of dividend funds that lean heavily toward stodgy value plays, Gabelli Dividend &...
US close: Markets rise despite bank sell-off as rate-cut hopes increase
ShareCast· 4 days agoInvestors were largely shrugging off an upside surprise to June's producer price index and instead...
Amgen (AMGN) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance UK· 4 days agoThe latest trading session saw Amgen (AMGN) ending at $330.83, denoting a +1.77% adjustment from its last day's close. This move outpaced the S&P 500's...
US open: Stocks trade higher following bank earnings
ShareCast· 5 days agoWall Street stocks were in the green early on Thursday as investors digested more key inflation data and a number of earnings from major US banks.
Pfizer (PFE) Moves Forward With Once-Daily Obesity Pill Study
Zacks via Yahoo Finance UK· 5 days agoVK2735 has shown impressive weight loss reductions in studies for both the subcutaneous (phase II)...
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance UK· 5 days agoAmgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Specialty pharmaceuticals to provide majority of sales by 2012 - Nature Reviews Drug Discovery
Nature· 5 days agoLarge pharmaceutical companies have increasingly been pursuing specialty pharmaceuticals — that is, drugs prescribed primarily by specialists rather than general practitioners (GPs). To investigate ...
Creating precision medicines for better care
Nature· 5 days agoDespite the huge advances in drug development over the past few decades, there are still many areas of unmet medical need. Byondis, based in Nijmegen, the Netherlands, is developing a pipeline ...
Millennium ends Takeda's US shopping spree - Nature Biotechnology
Nature· 5 days agoThe Millennium acquisition is the latest in a series of moves by the Osaka, Japan–based company to reinvent itself as a truly global player. In February, it inked a trillion-dollar agreement ...
